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Activated human polymorphonuclear neutrophils at inflamma-
tory sites release the chymotrypsin-like protease cathepsin G,
together with elastase and proteinase 3 (myeloblastin), from their
azurophil granules. The low activity of cathepsin G on synthetic
substrates seriously impairs studies designed to clarify its role in
tissue inflammation. We have solved this problem by producing
new peptide substrates with intramolecularly quenched fluor-
escence. These substrates were deduced from the sequence of
putative protein targets of cathepsin G, including the reactive
loop sequence of serpin inhibitors and the N-terminal domain
of the protease-activated receptor of thrombin, PAR-1. Two
substrates were selected, Abz-TPFSGQ-EDDnp and Abz-
EPFWEDQ-EDDnp, that are cleaved very efficiently by cathep-
INTRODUCTION
Cathepsin G is one of the three major serine proteinases of the
chymotrypsin family present in the azurophil granules of human
polymorphonuclear neutrophils (PMNs); the other two are
human neutrophil elastase (HNE) and proteinase 3 (Pr3; myelo-
blastin).All three enzymes are released fromactivated neutrophils
at the same time and in response to the same stimuli at
inflammatory sites [1]. Because they are released simultaneously
from primary granules and can all remain bound to neutrophil
membranes as active enzymes [2–4], the functions of these three
proteases during inflammation have not been yet clearly identi-
fied. All can participate, for example, in connective tissue
degradation (reviewed in [5]), regulation of cytokine bioactivity
[6] and inhibition of thrombin-induced cell activation [7], but the
contribution of cathepsin G is uncertain. Cathepsin G also
participates in a variety of other functions including platelet
activation [8], proteolysis of blood coagulation factors [9],
angiotensin II generation [10], chemotactic activity on monocytes
[11], and anti-fungal [12] and bactericidal [13] activity. It also
increases the susceptibility of monocytes}macrophages to acute
HIV-1 infection [14] and activates progelatinase B in itro more
efficiently than HNE or Pr3 [15]. Cathepsin G specificity differs
from those of HNE and Pr3, as it prefers a Phe or a Lys at P1
[16]. The chromogenic [p-nitroanilide (pNA)] and fluorogenic (7-
amino-4-methyl-coumarin hydrochloride) substrates most com-
monly used to measure cathepsin G activity have a Pro-Phe pair
at P2-P1 [17–19]. However, cathepsin G cleaves synthetic sub-
Abbreviations used: Abz, o-aminobenzoic acid ; ACT, a1-antichymotrypsin ; CMK, chloromethyl ketone; DTNB, 5,5«-dithio-bis(2-nitrobenzoic acid) ;
EDDnp, N-(2,4-dinitrophenyl)ethylenediamine; HNE, human neutrophil elastase ; PAR, protease-activated receptor ; PMN, polymorphonuclear
neutrophil ; pNA, p-nitroanilide ; Pr3, proteinase 3; SBzl, thiobenzyl ester ; Z, benzyloxycarbonyl ; Suc, succinyl ; MeOSuc, methoxysuccinyl.
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sin G but not by neutrophil elastase or proteinase 3, with
specificity constants (k
cat
}K
m
) in the 10& M−" [ s−" range. They
can be used to measure subnanomolar concentrations of free
enzyme in itro and at the surface of neutrophils purified from
fresh human blood. Purified neutrophils express 0.02–0.7 pg of
cathepsin G}cell (nfl 15) at their surface. This means that about
10% purified cells may be enough to record cathepsin G activity
within minutes. This may be most important for investigating the
role of cathepsin G as an inflammatory agent, especially in
bronchoalveolar lavage fluids from patients with pulmonary
inflammatory disorders.
Key words: kinetics, serine protease, synthetic substrate.
strates much more slowly than related chymotrypsin-like protein-
ases [18,20]. This seriously hampers studies of its biological
function and monitoring of its activity in biological fluids or in
tissue extracts, where it is present at low concentrations. We
recently designed a sensitive substrate derived from the a
"
-
antichymotrypsin (ACT) reactive-site loop that is more specific
than those currently used [21]. This resulted from a study of
optimal substrate occupation that included the prime side subsites
(S« sites) of the protease. But the first attempts to measure
cathepsin G activity in the presence of other neutrophil-derived
serine proteases showed that this substrate was also cleaved by
these proteases. We have therefore developed specific, sensitive
substrates of neutrophil cathepsin G to investigate the role of
this protease during inflammation and possibly use it as a target
for therapeutic drugs. These substrates were used to measure
cathepsin G activity at the surfaces of native and activated
PMNs.
The nomenclature used for the individual amino acid residues
(P
"
, P
#
, …) of a substrate and corresponding residues of the
enzyme subsites (S
"
, S
#
, ….) is that of Schechter and Berger [22].
EXPERIMENTAL
Chemicals
Human cathepsin G (EC 3.4.21.20) was from ICN Pharmaceuti-
cals. HNE (EC 3.4.21.37), Pr3 (EC 3.4.21.76), a
"
-proteinase
inhibitor and ACT were from Athens Research and Technology
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(Athens, GA, U.S.A.). Bovine chymotrypsin (EC 3.4.21.1) was
from Roche Molecular Biochemicals (Meylan, France). Human
recombinant chymase (EC 3.4.21.39) was provided by Professor
Norman Schechter (Department of Dermatology, University of
Pennsylvania, Philadelphia, PA,U.S.A.). Suc-AAPF-SBzl (where
Suc is succinyl and SBzl is thiobenzyl ester) was from Bachem
(Voisins-le-Bretonneux, France). Z-GLF-CMK (where Z is ben-
zyloxycarbonyl and CMK is chloromethyl ketone) and MeOSuc-
AAPA-CMK (where MeOSuc is methoxysuccinyl) were from
Enzyme System Products (Livermore, CA, U.S.A.). N,N-Di-
methylformamide and acetonitrile were from Merck (Darmstadt,
Germany), C
")
cartridges for reversed-phase chromatography
were from Touzart et Matignon (Paris, France) and Interchim
(Montluc: on, France). PolymorphprepTM and LymphoprepTM
were from Nycomed Pharma (Oslo, Norway). Igepal CA-630
was from Sigma (St. Louis, MO, U.S.A.). All other reagents were
of analytical grade.
Isolation and activation of blood PMNs
Human neutrophils were purified from 10 ml of peripheral blood
of volunteers (nfl 15) collected into EDTA-containing tubes.
Aliquots (5 ml) of blood were layered over 5 ml of Polymorph-
prep and centrifuged at 2000 g for 20 min at 25 °C. The neutro-
phil-enriched bands (75% PMNs and 25% lymphocytes) were
harvested, diluted with an equal volume of half-strength PBS and
centrifuged at 500 g for 10 min. The resulting pellet was washed
once with PBS, adjusted to 6 ml with PBS and layered over 3 ml
of Lymphoprep. After centrifugation at 1100 g for 20 min at
20 °C, the neutrophil band at the bottom of the gradient was
recovered and washed three times in PBS›1 mg}ml glucose›
4 mM EGTA at 500 g for 5 min at 20 °C. Residual erythrocytes
were removed by hypotonic lysis in 4 mM EGTA, pH 7.4.
Purified PMNs were pelleted at 500 g for 5 min and contami-
nating erythrocyte membranes were removed. The PMNs were
suspended in PBS›1 mg}ml glucose›4 mM EGTA to approx.
10% cells}ll, and their cathepsin G activity assayed. Differential
counting of cytocentrifuge preparations (Cytospin II ; Shandon)
and Hemacolor (Merck) staining showed " 99% PMNs, with
the remainder of the cells being eosinophils. These preparations
contained no monocytes, lymphocytes or platelets.
Design and synthesis of quenched fluorescent substrates
All quenched fluorogenic substrates were prepared by solid-
phase synthesis with the Fmoc (fluoren-9-ylmethoxycarbonyl)
methodology using a multiple automated peptide synthesizer
(PSSM-8; Shimadzu Co.) [23–25]. Glutamine was the C-terminal
residue in all peptides, due to a requirement of the synthesis
strategy [23]. Substrate purity was checked by matrix-assisted
laser-desorption ionization–time-of-flight MS (TofSpec-E;
Micromass) and by reversed-phase chromatography on a C
")
column eluted at 2 ml}min with a 10 min linear gradient of
acetonitrile (0–60%) in 0.075% trifluoroacetic acid.
Stock substrate solutions (2–5 mM) were prepared in 30%
(v}v) N,N-dimethylformamide and diluted to 0.5 mM with
50 mM Hepes buffer, pH 7.4.
Enzyme assays
Cathepsin G, chymotrypsin and chymase were titrated as re-
ported previously [21]. HNE and Pr3 were titrated with a
"
-
proteinase inhibitor, the titre of which had been determined
using bovine trypsin titrated with p-nitropheny-p«-guanidinoben-
zoate [26]. Experimental conditions were optimized, taking into
account the propensity of diluted solutions of neutrophil pro-
teases to stick to plastic and glass surfaces. Assays were carried
out at 37 °C in 300 ll of 50 mM Hepes buffer, pH 7.4, 100 mM
NaCl and 0.01% Igepal CA-630 (v}v) for cathepsin G and
chymotrypsin, 0.1 M Tris}HCl, pH 8.0, and 1.8 M NaCl for
chymase, and 50 mM Hepes, pH 7.4, 750 mM NaCl and 0.05%
Igepal CA-630 (v}v) for HNE and Pr3.
The hydrolysis of Abz-peptidyl-EDDnp [where Abz is
o-aminobenzoic acid and EDDnp is N-(2,4-dinitrophenyl)-
ethylenediamine] substrates was followed by measuring the
fluorescence at k
ex
fl 320 nm and k
em
fl 420 nm in a Hitachi
F-2000 spectrofluorometer. The system was standardized
using Abz-FR-OH prepared from Abz-FR-pNA total tryptic
hydrolysis, and its concentration was determined from the
absorbance at 410 nm, assuming e
%"!
fl 8800 M−" [ cm−" for
p-nitroaniline. Alternatively, Abz-peptidyl-EDDnp concen-
tration was determined by the absorbance measured at 365 nm,
with e
$’&
fl 17300 M−" [ cm−" for EDDnp.
All buffers were supplemented with the thiodisulphide reagent
5,5«-dithio-bis(2-nitrobenzoic acid) (‘DTNB’; 5 mM final) to
follow the hydrolysis of Suc-AAPF-SBzl (2.5–5 lM) by cathepsin
G and related proteases (2–5 nM final). This was followed at
405 nmand 37 °C with a ShimadzuUV-160A spectrophotometer.
Specificity constants (k
cat
}K
m
) were determined under first-
order conditions, using a substrate concentration far below the
estimatedK
m
, and a final cathepsin G concentration of 10–50 nM.
Under these conditions, the Michaelis–Menten equation is re-
duced to flk
obs
[S, where k
obs
flV
max
}K
m
. Integrating this
equation over time gives ln[S]flfik
obs
[ t›ln [S]
!
with [S]
!
being
the substrate concentrations at time 0 and [S] at time t. Since
V
max
flk
cat
[ [E]
t
, where [E]
t
is the final enzyme concentration,
dividing k
obs
by [E]
t
gives the k
cat
}K
m
ratio. The k
obs
for the first-
order substrate hydrolysis was calculated by fitting experimental
data to the first-order law using Enzfitter software (Elsevier
Science, Amsterdam, The Netherlands). The same experiments
were performed using chymotrypsin (7‹10−( M final), chymase
(20 nM final) and Abz-peptidyl-EDDnp substrates.
The observed K
m
values [K
m(obs)
] for the hydrolysis of Abz-
peptidyl-EDDnp by cathepsin G were determined using 8–10
substrate concentrations (0.1–10 lM); depending on the sub-
strate, the final concentration of cathepsin G was 10–100 nM.
Experimental data were fitted to the hyperbolic Michaelis–
Menten rate equation using Enzfitter. Direct measurements of
the Michaelis constant were not possible when substrate con-
centrations exceeded 10 lM, probably due to intermolecular
quenching. In that case, K
m(obs)
values were determined using
two competing substrates whose hydrolysis products could be
measured independently. Under these mixed alternative substrate
conditions, each substrate acts as a competitive inhibitor of the
other. K
m(obs)
values of intramolecularly quenched fluorogenic
substrates were obtained by measuring the dissociation con-
stant (K
i
) towards a chromogenic pNA substrate. Assays were
carried out by adding 5 nM cathepsin G to a mixture of 100–
500 lM Suc-AAPF-pNA (whose K
m
is 1.7‡0.2 mM [19]) and
0–50 lM fluorogenic Abz-peptidyl-EDDnp derivative. The hy-
drolysis of Suc-AAPF-pNA was monitored at 410 nm with less
than 5% of substrate hydrolysed. The velocity of the enzymic
reaction is described by the following equation:

i
}
o
fl (K
m
›S)}[K
m
[ (1›I}K
i
)›S] (1)
where 
i
is the initial velocity at a given substrate concentration
with the Abz-peptidyl-EDDnp competitor, 
o
is the initial velocity
at the same substrate concentration without competitor, K
m
is
the Michaelis constant of the substrate, S is the chromogenic
substrate concentration and I is the Abz-peptidyl-EDDnp sub-
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strate concentration. The K
i
value corresponds to the observed
Michaelis constant [K
m(obs)
] of Abz-peptidyl-EDDnp substrate as
a competitor.
Enzymic activity at the surface of PMNs
Purified PMNs (10%–10&) were incubated in 50 mM Hepes buffer,
pH 7.4, 150 mM NaCl and 0.05% Igepal CA-630 (v}v) with
5 lM Abz-peptidyl-EDDnp substrate in 200 ll of reaction me-
dium in microplate wells at 37 °C. The fluorescence was recorded
using a Spectra Max Gemini microplate fluorescence reader
(Molecular Devices) that allows continuous stirring during the
course of the reaction. The enzyme activity in supernatants
obtained by washing PMNs in PBS was also assayed. CMK
inhibitors Z-GLF-CMK and MeOSuc-AAPA-CMK were as-
sayed at final concentrations of 10−% M and incubated with
PMNs for 2 h at 37 °C before measuring residual activity
with Abz-TPFSGQ-EDDnp.
Chromatographic procedures and analysis of peptide products
Once the enzyme reaction was complete, the reaction medium
was incubated with 4 vol. of absolute ethanol for 15 min on ice
and centrifuged at 13000 g for 10 min. The supernatant con-
taining the hydrolysis products was recovered, air-dried under
vacuum and dissolved in 200 ll of 0.01% trifluoroacetic acid
(v}v). Hydrolysis fragments were purified by reversed-phase
chromatography on a C
")
column (2.1 mm‹30 mm, Brownlee;
or 2 mm‹33 mm, Uptisphere), using a Thermo Separation
Products P200 pump and a Spectrasystem UV3000 detector
(Thermo Separation Products), at a flow rate of 0.3 ml}min, with
a linear (0–60%, v}v) gradient of acetonitrile in 0.01% trifluoro-
acetic acid over 20 min. Eluted peaks were monitored at three
wavelengths (220, 320 and 360 nm) simultaneously, which al-
lowed the direct identification of EDDnp-containing peptides
prior to sequencing. Cleavage sites were identified by N-terminal
sequencing using an Applied Biosystems 477A pulsed liquid se-
quencer with the chemicals and program recommended by the
manufacturer. Phenylthiohydantoin derivatives were identified
with an online model 120A analyser.
RESULTS AND DISCUSSION
It is difficult to investigate the biological function of cathepsin G
because of its poor capacity to cleave synthetic peptide substrates
as compared with related chymase-like proteases such as chymo-
trypsin and chymase [18,20,21]. There is little doubt that cathep-
sin G is intimately involved in the metabolism of PMNs and
particularly the function of azurophil granules [1]. But the roles
of the azurophil granule proteases in biological fluids and tissues
Table 1 Specificity constants (kcat/Km) for the hydrolysis of fluorogenic substrates by the three serine proteases of PMNs, and chymase and chymotrypsin
The kcat/Km values for the hydrolysis of Suc-AAPF-SBzl are given for comparison. Values are means‡S.D. (n fl 3).
kcat/Km (mM−
1 [ s−1)
Substrate Cathepsin G Pr3 Elastase Chymase Chymotrypsin
Abz-TPFSALQ-EDDnp 153.8‡4.9* 11.5‡1.7 7.11‡0.04 1870.0‡27.0* 231.3‡6.4*
Abz-TPFSGQ-EDDnp 161.9‡5.4 ! 1 ! 1 1018.7‡20.1 117.9‡1.9
Abz-EPFWEDQ-EDDnp 242.7‡2.9 No hydrolysis ! 1 459.3‡12.0 No hydrolysis
Suc-AAPF-SBzl 2096‡358 No hydrolysis 69.7‡5.6 17033‡888 11025‡248
* Values from Re! hault et al. [21].
can only be determined when sensitive, specific substrates are
available for each protease. We have already produced a fluoro-
genic cathepsin G substrate of great sensitivity, its specificity
constant (k
cat
}K
m
) being greater than 10& M−" [ s−" [21]. This
chimaeric substrate was derived from the sequence of the reactive-
site loop of ACT, a fast-acting serpin inhibitor of cathepsin G, by
placing a Pro-Phe pair at P2-P1 in the fluorogenic substrate Abz-
TPFSALQ-EDDnp. As cathepsin G is released from activated
neutrophils at the same time as HNE and Pr3 at inflammatory
sites, we first used Abz-TPFSALQ-EDDnp as a substrate for
these two proteases and found that it was hydrolysed at a low
rate by both of them (Table 1).
Designing a new, sensitive substrate from Abz-TPFSALQ-EDDnp
The cleavage sites in Abz-TPFSALQ-EDDnp by all three pri-
mary granule serine proteases were identified by reversed-phase
HPLC and N-terminal sequencing of the EDDnp-containing
fragments. This showed that cathepsinGhydrolysed the substrate
at the F–S bond, whereas HNE cleaved at the L–Q bond and
Pr3 at the S–A bond (Figure 1). Although the k
cat
}K
m
for HNE
and Pr3 were lower than that for cathepsin G (Table 1) and the
cleavage sites differed for the three proteases, Abz-TPFSALQ-
EDDnp is not ideally suited for measuring cathepsin G specifi-
cally in biological samples where the other PMN serine proteases
may be present. We therefore produced a new substrate lacking
the HNE and Pr3 cleavage sites by replacing the A–L pair with
a G residue, which is generally not accomodated by the S1
subsite of these proteases. The resulting substrate (Abz-
TPFSGQ-EDDnp) was hydrolysed by cathepsin G with a k
cat
}K
m
in the 10& M−" [ s−" range, similar to that of the former substrate,
but was resistant to HNE and Pr3 hydrolysis (Table 1). The
K
m(obs)
was 38.7 lM, which is in the same range as that reported
for Abz-TPFSALQ-EDDnp [21]. This value was determined by
competition experiments with the chromogenic pNA substrate
Suc-AAPF-pNA, because intermolecular quenching might occur
at Abz-peptidyl-EDDnp concentrations above 10 lM. Chymo-
trypsin and chymase, two related enzymes that differ from
cathepsin G by their potent activity on synthetic substrates, also
cleave Abz-TPFSGQ-EDDnp but less efficiently than Abz-
TPFSALQ-EDDnp (Table 1). The same is true for the currently
used substrate Suc-AAPF-SBzl, which is cleaved more rapidly by
chymase and chymotrypsin than by cathepsin G and is also a
substrate for HNE (Table 1).
Abz-EPFWEDQ-EDDnp, a sensitive protease-activated receptor
(PAR)-1-derived cathepsin G substrate resistant to HNE and Pr3
In addition to serpins, whose reactive-site loop is cleaved in a
substrate-like manner by cathepsin G, some other natural protein
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Figure 1 Identification of the cleavage sites within Abz-TPFSALQ-EDDnp
after hydrolysis by azurophil granule serine proteases from human PMNs
Reversed-phase HPLC chromatograms of the substrate after hydrolysis by cathepsin G, elastase
and Pr3. (A) 10 lM Abz-TPFSALQ-EDDnp, no enzyme. (B) 10 lM Substrate›10−8 M
cathepsin G. (C) 10 lM Substrate›5‹10−8 M Pr3. (D) 10 lM Substrate›5‹10−8 M
elastase. The peaks eluting at 23 min correspond to Igepal CA-630. The cleavage sites were
identified by N-terminal sequencing of the EDDnp-containing fragments having an absorbance
peak at 360 nm. For the sake of clarity, absorbances at 320 nm (Abz-) and 360 nm (-EDDnp)
are not reported.
targets of this protease, including members of the PAR family,
have been identified [7,8,27,28]. PAR-1 and PAR-3 are inacti-
vated by cathepsin G and by other neutrophil proteases, thus
blocking the cell activation induced by thrombin [7,27], whereas
PAR-4 is activated by cathepsin G in human platelets [8]. A
cathepsin G-sensitive sequence in the exodomain of the thrombin
receptor PAR-1 has a Pro-Phe pair at P2-P1 and is specifically
cleaved by cathepsinG [7].Wehave produced an intramolecularly
quenched fluorescent peptide based on this sequence on both
sides of the cathepsin G-cleavage site (Phe-55–Trp-56). This
Figure 2 Identification of the cleavage site within Abz-TPFSGQ-EDDnp
after hydrolysis by free cathepsin G and purified PMNs
Reversed-phase HPLC chromatograms of: (A) 5 lM Abz-TPFSGQ-EDDnp and no enzyme; (B)
5 lM substrate›10−8 M cathepsin G; and (C) 5 lM substrate›4‹104 purified PMNs. The
peaks eluting at 25 min correspond to Igepal CA-630. The cleavage sites were identified by N-
terminal sequencing of the EDDnp-containing fragments having an absorbance peak at 360 nm.
An identical cleavage site was also found in Abz-EPFWEDQ-EDDnp with purified cathepsin G
and neutrophils (not shown). For clarity, absorbances at 320 nm (Abz-) and 360 nm (-EDDnp)
are not reported.
substrate (Abz-EPFWEDQ-EDDnp) is rapidly cleaved by cath-
epsin G with a cleavage site at the F–W bond and a k
cat
}K
m
in
the same range as that reported for Abz-TPFSGQ-EDDnp
(Table 1). We found however that the K
m(obs)
was significantly
lower than that for Abz-TPFSGQ-EDDnp so that it could be
determined either directly by recording reaction rates at different
substrate concentrations or by competition with Suc-AAPF-
pNA (Table 1). The reason why the K
m(obs)
value towards Abz-
EPFWEDQ-EDDnp is lower than that of Abz-TPFSGQ-
EDDnp remains a matter for conjecture. It could be that the
presence of three negatively charged residues at P3, P2« and P3«
in the former favours substrate binding in a non-productive
mode at the active site of cathepsin G. Such binding results in a
decrease in both K
m
and k
cat
without altering the value of the
specificity constant k
cat
}K
m
[29].
Abz-EPFWEDQ-EDDnp is completely resistant to hydrolysis
by HNE and Pr3 so that it can be used to follow cathepsin G
activity in biological fluids or at the surface of cells when all three
proteases are present. Abz-EPFWEDQ-EDDnp is also com-
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Table 2 Michaelis constants (Km) for the hydrolysis of fluorogenic
substrates by cathepsin G
Values are means‡S.D. (n fl 2).
Substrate Km(obs) (lM)
Abz-TPFSALQ-EDDnp 10.7‡1.8
Abz-TPFSGQ-EDDnp 38.7‡2.5
Abz-EPFWEDQ-EDDnp 1.1‡0.1
pletely resistant to chymotrypsin and is cleaved by mast cell
chymase far less efficiently than several other substrates of this
strongly reactive protease [21].
Cathepsin G activity at the surface of PMNs
Because of their great sensitivity and selectivity, Abz-
EPFWEDQ-EDDnp and Abz-TPFSGQ-EDDnp were used to
measure cathepsin G activity at the surface of purified neutro-
phils. SBzl substrates could not be used for this purpose since, in
addition to their lack of specificity, kinetic measurements using
this kind of substrate require an additional thiodisulphide reagent
that interferes with any free thiol groups present in reaction
mixtures containing cells or unfractionated biological fluids.
Suspensions of purified blood neutrophils containing as few as
10% cells}200 ll cleaved both substrates. This activity remained
after the cells were washed with PBS, centrifuged and suspended
in the reaction buffer, demonstrating that the activity was on the
cell membranes. HPLC analysis of the soluble fraction after
incubation of cells with fluorogenic substrates showed that both
substrates were cleaved at a single site, identical with that of
cathepsin G (Figure 2). The membrane-bound protease hydro-
lysed Abz-EPFWEDQ-EDDnp less rapidly than Abz-TPFSGQ-
EDDnp, unlike free cathepsin G. It is unlikely that there is
another protease which cleaves Abz-TPFSGQ-EDDnp but not,
or to a lesser extent, Abz-EPFWEDQ-EDDnp at the surface of
neutrophils because each substrate is hydrolysed at a single and
identical site by free and membrane-bound cathepsin G (Figure
2) and activity is completely inhibited by the irreversible low-M
r
cathepsin G inhibitor Z-GLF-CMK but not by the elastase-like
inhibitor MeOSuc-AAPA-CMK (not shown). More probably,
the three negative charges on the peptidyl moiety of Abz-
EPFWEDQ-EDDnp impair access to the negatively charged
membrane surface. We checked this by measuring the rate of
hydrolysis of increasing concentrations (1–10 lM) of Abz-
EPFWEDQ-EDDnp by free and membrane-bound cathepsin G.
The K
m(obs)
for the membrane-bound enzyme (6‡1 lM) was
significantly higher than that for free cathepsin G (Table 2),
which explains the slower hydrolysis of Abz-EPFWEDQ-
EDDnp by membrane-bound cathepsin G. It also suggests that
free and membrane-bound cathepsin G cleave physiological
target substrates differently, as already observed for angiotensin
II generation [10]. As membrane-bound proteases from the
azurophil granules of PMNs are also remarkably resistant to
naturally occurring serpin proteinase inhibitors [3,4], their role
during inflammation could differ significantly depending on
whether they are on the surface of cells or released into
extracellular medium.
Based on the assumption that Abz-TPFSGQ-EDDnp is
cleaved similarly by free and membrane-bound cathepsin G, it
was used to quantify cathepsin G at the surface of purified
neutrophils. We used a linear standard curve from 5‹10−"! M to
5‹10−) M cathepsin G and assayed 10%–10& cells in a final
volume of 200 ll. The number of cells was adjusted to obtain a
final cathepsin G molar concentration in the range 0.5–1.5 nM.
In these conditions, purified neutrophils expressed 0.02–0.7 pg
cathepsin G}cell (nfl 15) at their surface (median value 0.35 pg}
cell). This corresponds to about 10–20% of the cellular content
of this neutral protease and agrees with the data of Owen et al.
[30].
Thus, the substrates described above are suitable for directly
measuring subnanomolar concentrations of cathepsin G at the
surface of purified human blood neutrophils. It is not clear at
present whether blood neutrophils bear cathepsin G and other
azurophil granule proteases on their surface constitutively, or
whether the cell-surface activity is due to partial degranulation
during purification. Nevertheless, the fluorogenic substrates
described here may be most useful for investigating the role of
cathepsin G in the cellular and soluble fraction of bronchoalveo-
lar lavage fluids from patients suffering from pulmonary inflam-
matory disorders where PMNs have been recruited and activated.
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